Multiple Dose Administration Of Mk-0431 (Sitagliptin), An Inhibitor Of Dipeptidyl Peptidase-Iv, Does Not Meaningfully Alter The Plasma Pharmacokinetics Or Pharmacodynamics Of Single Doses Of Warfarin.
CLINICAL PHARMACOLOGY & THERAPEUTICS（2006）
Key words
sitagliptin,plasma pharmacokinetics,pharmacodynamics,warfarin
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined